Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Medicine

• Publication date

  2006-05-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nm1416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft‐versus‐host disease

  2006cited by this paper
• Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

  2005cited by this paper
• Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

  2005cited by this paper
• Clinical uses of intravenous immunoglobulin

  2005cited by this paper
• Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.

  2005cited by this paper
• The Inositol 3-Phosphatase PTEN Negatively Regulates Fcγ Receptor Signaling, but Supports Toll-Like Receptor 4 Signaling in Murine Peritoneal Macrophages1

  2004cited by this paper
• Immunoglobulin for rheumatic diseases in the twenty‐first century: take it or leave it?

  2003cited by this paper
• Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.

  2003cited by this paper
• Intravenous immune globulins: an update for clinicians

  2003cited by this paper
• Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

  2003cited by this paper
• Mechanism of action of IVIG and anti-D in ITP.

  2003cited by this paper
• IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.

  2003cited by this paper
• Immune pathophysiology of autoimmune thrombocytopenic purpura.

  2002cited by this paper
• Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.

  2002cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

  2001cited by this paper
• Fc receptor blockade and immune thrombocytopenic purpura.

  2000cited by this paper
• From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

  1999cited by this paper
• Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages

  1998cited by this paper
• Organ-specific disease provoked by systemic autoimmunity.

  1996cited by this paper
• Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit.

  1992cited by this paper
• Phosphoinositide breakdown is associated with Fc-gamma RII-mediated activation of 5'-lipoxygenase in murine eosinophils.

  1991cited by this paper
• Monocyte-platelet interaction in immune and nonimmune thrombocytopenia.

  1989cited by this paper
• Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D))

  1984cited by this paper
• Effect of intravenous immunoglobulin in immune thrombocytopenia.

  1983cited by this paper
• Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

  1982cited by this paper
• Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura.

  1974cited by this paper
• STERILISATION BY STEAM UNDER INCREASED PRESSURE; A THIRD COMMUNICATION TO THE MEDICAL RESEARCH COUNCIL BY THE WORKING PARTY ON PRESSURE-STEAM STERILISERS.

  1964cited by this paper

• Intravenous immunoglobulin remodels innate immune cell communication and induces differential autophagy pathways in Kawasaki disease

  2026cites this paper
• Predictors of progression to chronicity in newly diagnosed primary immune thrombocytopenia: a retrospective multicenter French study

  2025cites this paper
• Autoantibodies in COVID-19: implications for disease severity and clinical outcomes

  2025cites this paper
• The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

  2024cites this paper
• The Establishment of a Novel Murine Model of Immune Thrombocytopenia in Pregnancy and the Impacts of Thrombopoietin Receptor Agonist on Platelet Production

  2024cites this paper
• Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome

  2023cites this paper
• Production of recombinant human IgG1 Fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens

  2023cites this paper
• Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

  2023cites this paper
• Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1.

  2023cites this paper
• Acquired immunity and Alzheimer's disease

  2022cites this paper
• The Extensive Regulation of MicroRNA in Immune Thrombocytopenia

  2022cites this paper
• Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy

  2020cites this paper
• Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia.

  2020cites this paper
• Differential Role for Activating FcγRIII in Neointima Formation After Arterial Injury and Diet-Induced Chronic Atherosclerosis in Apolipoprotein E-Deficient Mice

  2020cites this paper
• New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases

  2020cites this paper
• Neuroinflammation after SCI: Current Insights and Therapeutic Potential of Intravenous Immunoglobulin

  2020cites this paper
• Current perspective and scope of fetal therapy: part 2

  2020cites this paper
• High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy.

  2019cites this paper
• Anti-inflammatory Activity of IgG-Fc.

  2019influential citation
• The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms.

  2019cites this paper
• Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer

  2019cites this paper
• Intravenous immunoglobulin (IVIg) acts directly on conventional T cells to suppress T cell receptor signaling.

  2019cites this paper
• Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs

  2019cites this paper
• Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia.

  2019cites this paper
• Intravenous immunoglobulin (IVIg) or IVIg‐treated macrophages reduce DSS‐induced colitis by inducing macrophage IL‐10 production

  2019cites this paper
• Inhibition of osteoclastogenesis by opsonized Porphyromonas gingivalis

  2019cites this paper
• Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools

  2019cites this paper
• Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.

  2019cites this paper
• A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity.

  2019cites this paper
• CHAPTER 1: Literature review

  2018cites this paper
• Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion

  2018cites this paper
• Targeted Therapies for Autoimmune Bullous Diseases: Current Status

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• Mechanisms of Action and Immunomodulation by IVIg

  2018cites this paper
• Cellular Contact between Red Blood Cell and Endothelial Cells after High Dose Immunoglobulin Therapy Might Depend on Non-Immunological Mechanism

  2018cites this paper
• GM‐CSF and IL‐4 are not involved in IVIG‐mediated amelioration of ITP in mice: a role for IL‐11 cannot be ruled out

  2018cites this paper
• Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation

  2017cites this paper
• Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia

  2017cites this paper
• In-bag enzymatic splenic digestion: a novel alternative to manual morcellation?

  2017cites this paper
• IVIG-mediated effector functions in autoimmune and inflammatory diseases

  2017cites this paper
• Therapeutic Effects of Intravenous Immunoglobulin, Platelet Transfusion and B Cell Depletion on Murine Immune Thrombocytopenia (ITP)

  2016cites this paper
• Anti-RBC Antibody Mediated Erythrocyte Phagocytosis and its Therapeutic Role in Immune Thrombocytopenia (ITP)

  2016cites this paper
• Comparison between IV immune globulin (IVIG) and anti‐D globulin for treatment of immune thrombocytopenia: a randomized open‐label study

  2016cites this paper
• Multiple immune deviations predictive for IVF failure as possible markers for IVIG therapy.

  2016cites this paper
• Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells.

  2016cites this paper
• Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.

  2016cites this paper
• Intravenous immune globulin suppresses angiogenesis in mice and humans

  2016cites this paper
• B Cells and Regulatory B Cells in Cancer Escape

  2016cites this paper
• Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia

  2015cites this paper
• Thrombocytopenia in Pregnancy: Gestational Thrombocytopenia and Immune Thrombocytopenic Purpura

  2015cites this paper
• Immunomodulatory Effects of Intravenous Immunoglobulin - Assembling a Jigsaw Puzzle

  2014cites this paper
• Prevention of immunoglobulin G immobilization eliminates artifactual stimulation of dendritic cell maturation by intravenous immunoglobulin in vitro.

  2014cites this paper
• dependent prostaglandin E2 in human dendritic cells - cyclooxygenase-2 Intravenous immunoglobulin expands regulatory T cells via induction of

  2014cites this paper
• Three major uncertainties in the antibody therapy of cancer

  2014cites this paper
• Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute

  2014cites this paper
• Current Pathways for Immune Manipulation

  2014cites this paper
• Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G.

  2014cites this paper
• Polyclonal and monoclonal antibodies in clinic.

  2014cites this paper
• Dose-related regulatory effect of intravenous immunoglobulin on dendritic cells-mediated immune response

  2014cites this paper
• The function of Fcγ receptors in dendritic cells and macrophages

  2014cites this paper
• Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute

  2014cites this paper
• Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

  2013cites this paper
• Tumor-Evoked Regulatory B Cells as Important Mediators of Cancer Escape

  2013cites this paper
• Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.

  2013cites this paper
• Molecular and Cellular Pathways Involved in the Anti-inflammatory Activity of IgG

  2013cites this paper
• Development of Autoimmune Diabetes in Receptors Participate in the γ Activating Fc

  2013cites this paper
• idiopathic thrombocytopenic purpura gene predisposes to FCGR2C Copy number variation of the activating

  2013cites this paper
• Type II Activation of Macrophages and Microglia: Roles in T cell biasing and experimental autoimmune encephalomyelitis

  2013cites this paper
• Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway

  2013cites this paper
• autoimmune encephalomyelitis immunoglobulin: a critical factor in controlling experimental Expansion of CD4+CD25+ regulatory T cells by intravenous

  2013cites this paper
• Interrogation and modulation of the myeloid aspect of the inflammatory immune response in spinal cord injury

  2013cites this paper
• INTERLEUKIN-11 IS A KEY MEDIATOR OF INTRAVENOUS IMMUNOGLOBULIN EFFECTS IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

  2013cites this paper
• Pathogenesis of Fetal and Neonatal Immune Thrombocytopenia: Role of Anti-Beta3 Integrin Antibodies in Vascular Injury and Angiogenesis

  2013cites this paper
• A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity.

  2013cites this paper
• masks the heterogeneity of leukemia-initiating cells mediated clearance of human repopulating cells - Anti-CD38 antibody

  2013cites this paper
• Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

  2013cites this paper
• Identification and Characterization of the Receptor for the Soluble Fibrinogen Like Protein 2 (FGL2)

  2012cites this paper
• Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

  2012cites this paper
• Anti-CD44 and Anti-platelet Antibodies have Similar but Distinct Effects in the Treatment of a Mouse Model of Arthritis

  2012cites this paper
• 30 years of immunomodulation by intravenous immunoglobulin.

  2012cites this paper
• Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function.

  2012cites this paper
• [Psychological and social impact of online gambling].

  2012cites this paper
• Modulation of dendritic cells and regulatory T cells by naturally occurring antibodies.

  2012cites this paper
• Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review.

  2012cites this paper
• Mécanismes d'action des immunoglobulines.

  2012cites this paper
• Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.

  2012cites this paper
• Sialylation‐independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

  2012cites this paper
• Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.

  2012cites this paper
• "Despite the difficulty in defining the multiple and complex mechanisms of action of intravenous immuno gobulin, this biological drug - be it transiently or for long‑term benefit - became essential for many patients ..."

  2012cites this paper
• Apoptosis in the anucleate platelet.

  2012cites this paper
• Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice.

  2011cites this paper
• Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes.

  2011cites this paper
• A vital role for IL-2 trans-presentation in DC-mediated T cell activation in humans as revealed by daclizumab therapy

  2011cites this paper
• Induction and Function of Antigen-specific Sialylated IgG Antibodies

  2011cites this paper
• Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?

  2011cites this paper
• Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation.

  2011cites this paper
• Eltrombopag for the treatment of chronic immune thrombocytopenia

  2011cites this paper
• Adoptive-Transfer Effects of Intravenous Immunoglobulin in Autoimmunity

  2010cites this paper
• Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP)

  2010cites this paper
• Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders

  2010cites this paper